Structural basis of the lisinopril-binding specificity in N- and C-domains of human somatic ACE

Biochemical and Biophysical Research Communications

Volumn 308, Issue 2, 2003, Pages 219-226

  Fernandez, Jorge H ^a   Hayashi, Mirian A F ^b   Camargo, Antonio C M ^b   Neshich, Goran ^a  

^a EMBRAPA INFORMÁTICA AGROPECUÁRIA   (Brazil)

^b NONE

Author keywords

Angiotensin I converting enzyme; BPPs; Homology modeling; Lisinopril; Somatic ACE

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; PROLINE; TYROSINE;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BLOOD PRESSURE REGULATION; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYMOLOGY; HUMAN; HYDROPHOBICITY; MOLECULAR DYNAMICS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 0043095438     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01363-9     Document Type: Article

References (43)

1. Skeggs L.T., Kahn J.R., Shumway N.P. The preparation and function of hypertensin-converting enzyme. J. Exp. Med. 103:1956;295-299.
2. Esther C.R. Jr., Marino E.M., Howard T.E., Corvol P., Capecchi M.R., Bernstein K.E. The critical role of the tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J. Clin. Invest. 99:1997;2375-2385.
3. Linz W., Wiemer G., Gohlke P., Unger T., Scholkens B.A. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev. 47(1):1995;25-49.
4. Villar E., Soubrier F. Molecular biology and genetics of the angiotensin-I-converting enzyme: potential implications in cardiovascular diseases. Cardiovasc. Res. 32:1996;999-1007.
5. Ferreira S.H., Rocha e Silva M. Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom. Experientia. 21:1965;347-349.
6. Ferreira S.H., Greene L.H., Alabaster V.A., Bakhle Y.S., Vane J.R. Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme. Nature. 225(230):1970;79-380.
7. Ferreira S.H., Bartelt D.C., Greene L.J. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry. 9(13):1970;2583-2593.
8. Ondetti M.A., Cushman D.W. Inhibitors of angiotensin-converting enzyme. Soffer R.L. Biochemical Regulation of Blood Pressure. 1981;165-204 Wiley, New York.
9. Waeber B., Nussberger J., Brunner H.S. Laragh, Brenner Hypertension: Pathophysiology, Diagnosis and Management. 1990;Raven Press, New York.
10. El-Dorry H.A., Bull H.G., Iwata K., Thornberry N.A., Cordes E.M., Soffer R.L. Molecular and catalytic properties of rabbit testicular dipeptidyl carboxypeptidase. J. Biol. Chem. 257:1982;14128-14133.
11. Lattion A.L., Soubrier F., Allegrini J., Hubert C., Corvol P., Alhenc-Gelas F. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett. 252:1989;99-104.
12. Ehlers M.R.W., Fox E.A., Strydom D.J., Riordam J.F. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc. Natl. Acad. Sci. USA. 86:1989;7741-7745.
13. Kumar R.S., Kusari J., Roy S.N., Soffer R.L., Sen G.C. Structure of testicular angiotensin-converting enzyme: a segmental mosaic enzyme. J. Biol. Chem. 264:1989;16754-16758.
14. Wei L., Clauser E., Alhenc-Gelas F., Corvol P. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J. Biol. Chem. 267(19):1992;13398-13405.
15. Jaspard E., Wei L., Alhenc-Gelas F. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J. Biol. Chem. 268:1993;9496-9503.
16. Deddish P.A., Marcic B., Jackman H.L., Wang H.Z., Skidgel R.A., Erdos E.G. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE. Hypertension. 31:1998;912-917.
17. Rousseau A., Michaud A., Chauvet M.T., Lenfant M., Corvol P. The haemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J. Biol. Chem. 270:1995;3656-3661.
18. Cotton J., Hayashi M.A., Cuniasse P., Vazeux G., Ianzer D., Camargo A.C., Dive V. Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides. Biochemistry. 41(19):2002;6065-6071.
19. M.A.F. Hayashi, A.F. Murbach, D. Ianzer, F.C.V. Portaro, B.C. Prezoto, P.F. Silveira, C.A. Silva, R.S. Pires, L.R.G. Britto, V. Dive, A.C.M. Camargo, The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme, J. Neurochem. (2003) in press.
20. D. Georgiadis, F. Beau, B. Czarny, J. Cotton, A. Yiotakis, V. Dive, Roles of the two active sites of somatic ACE in the cleavage of angiotensin I and bradykinin. Insights from selective inhibitors, Circ. Res. (2003) submitted.
21. Kim H.M., Shin D.R., Yoo O.J., Lee H., Lee J.O. Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril(1). FEBS Lett. 538:2003;65-70.
22. Natesh R., Schwager S., Sturrock E., Acharya K. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature. 421:2003;551-554.
23. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234:1993;779-815.
24. Neshich G., Togawa R., Mancini A., Kuser P., Yamagishi M., Pappas G., Campos T., Luna F., Oliveira A., Miura R., Inoue M., Horita L., Dominiquini F., Álvaro A., Gomes G., Freitas E., Mattiuz A., Souza S., Baudet C., Higa R. STING Millennium: a Web based suite of programs for comprehensive and simultaneous analysis of protein structure and sequence. N.A.R. 31(13):2003;3386-3392.
25. Lindahl E., Hess B., van der Spoel D. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J. Mol. Modeling. 7:2001;306-317.
26. Soubrier F., Alhenc-Gelas F., Hubert C., Allegrini J., John M., Tregear G., Corvol P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. USA. 85:1988;9386-9390.
27. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680.
28. Fiser A., Do R.K., Sali A. Modeling of loops in protein structures. Protein Sci. 9:2000;1753-1773.
29. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., Karplus M. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J. Comp. Chem. 4:1983;187-217.
30. Marti-Renom M.A., Stuart A., Fiser A., Sánchez R., Melo F., Sali A. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29:2000;291-325.
31. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26:1993;283-291.
32. van Aalten D.M.F., Bywater R., Findlay J.B.C., Hendlich M., Hooft R.W.W., Vriend G. PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules. J. Comput. Aided Mol. Design. 10:1996;255-262.
33. Pellegrini M., Bremer A.A., Ulfers A.L., Boyd N.D., Mierke D.F. Molecular characterization of the substance P*neurokinin-1 receptor complex: development of an experimentally based model. J. Biol. Chem. 276(25):2001;22862-22867.
34. Louie T.M., Yang H., Karnchanaphanurach P., Xie X.S., Xun L. FAD is a preferred substrate and an inhibitor of Escherichia coli general NAD(P)H:flavin oxidoreductase. J. Biol. Chem. 277(42):2002;39450-39455.
35. Essman U., Perela L., Berkowitz M.L., Darden T., Lee H., Pedersen L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 103:1995;8577-8592.
36. Shindyalov I.N., Bourne P.E. Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. Protein Eng. 11(9):1998;739-747.
37. Yang A.S., Honig B. Sequence to structure alignment in comparative modeling using PrISM. Proteins: Struc., Funct. Genet. 3:1999;66-72.
38. Kabsch W., Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 22:1983;2577-2637.
39. Wei L., Alhenc-Gelas F., Corvol P., Clauser E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J. Biol. Chem. 266:1991;9002-9008.
40. Liu X., Fernandez M., Wouters M.A., Heyberger S., Husain A. Arg(1098) is critical for the chloride dependence of human angiotensin I-converting enzyme C-domain catalytic activity. J. Biol. Chem. 276(36):2001;33518-33525.
41. McGaughey G.B., Gagné M., Rappé A. π-Stacking interactions: alive and well in proteins. J. Biol. Chem. 273:1998;15458-15463.
42. Baxter N.J., Lilley T.H., Haslam E., Williamson M.P. Multiple interactions between polyphenols and a salivary proline-rich protein repeat result in complexation and precipitation. Biochemistry. 36(18):1997;5566-5577.
43. Verge S., Richard T., Moreau S., Nurich A., Merillon J.M., Vercauteren J., Monti J.P. First observation of solution structures of bradykinin-penta-O-galloyl-D-glucopyranose complexes as determined by NMR and simulated annealing. Biochim. Biophys. Acta. 1571(2):2002;89-101.